Hefei Hengxin Life Science and Technology Co., Ltd. (SHE:301501)
China · Delayed Price · Currency is CNY 42.54
-0.25 (-0.58%)
Feb 13, 2026, 3:04 PM CST
SHE:301501 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 242.77 | 219.89 | 213.86 | 162.77 | 80.16 | 26.09 |
Depreciation & Amortization | 75.78 | 75.78 | 50.22 | 38.36 | 27.2 | 20.02 |
Other Amortization | 3.62 | 3.62 | 2.61 | 2.5 | 1.09 | 0.8 |
Loss (Gain) From Sale of Assets | -0.88 | -0.88 | 0.3 | -0.24 | -0.05 | - |
Asset Writedown & Restructuring Costs | 0.51 | 0.51 | 2.41 | 1.17 | 0.01 | 0.56 |
Loss (Gain) From Sale of Investments | 0 | 0 | 2.14 | 5.5 | 11.24 | 8.1 |
Provision & Write-off of Bad Debts | 0.88 | 0.88 | 3.23 | 2.13 | 0.42 | 0.71 |
Other Operating Activities | 1.69 | 14.43 | 15.79 | 9.07 | 6.18 | 2.98 |
Change in Accounts Receivable | -16.22 | -16.22 | -71.51 | -44.84 | -29.66 | -3.26 |
Change in Inventory | 11.94 | 11.94 | -30.63 | -52.86 | -27.74 | -47.18 |
Change in Accounts Payable | 76.78 | 76.78 | 37.93 | 171.37 | 74.09 | -13.36 |
Change in Other Net Operating Assets | 0.75 | 0.75 | 0.67 | 0.19 | - | 37.6 |
Operating Cash Flow | 391.01 | 380.86 | 219.49 | 292.65 | 143.85 | 32.34 |
Operating Cash Flow Growth | 78.14% | 73.52% | -25.00% | 103.44% | 344.81% | -70.75% |
Capital Expenditures | -494.79 | -459.69 | -330.35 | -290.07 | -134.1 | -59.45 |
Sale of Property, Plant & Equipment | 0.88 | 0.05 | 0.37 | 0.56 | 0.8 | - |
Investment in Securities | -487 | - | - | 0.01 | - | -0.71 |
Other Investing Activities | 0.78 | - | - | 0 | -1.19 | -4.45 |
Investing Cash Flow | -980.14 | -459.64 | -329.98 | -289.49 | -134.49 | -64.61 |
Short-Term Debt Issued | - | - | - | - | - | 35 |
Long-Term Debt Issued | - | 279.49 | 153.64 | 196.99 | 12.35 | - |
Total Debt Issued | 80 | 279.49 | 153.64 | 196.99 | 12.35 | 35 |
Short-Term Debt Repaid | - | - | - | - | - | -55 |
Long-Term Debt Repaid | - | -119.1 | -82.78 | -55.25 | -35 | - |
Total Debt Repaid | -296.42 | -119.1 | -82.78 | -55.25 | -35 | -55 |
Net Debt Issued (Repaid) | -216.42 | 160.39 | 70.85 | 141.74 | -22.65 | -20 |
Issuance of Common Stock | 933.36 | - | - | - | 52.56 | 11.3 |
Common Dividends Paid | -61.46 | -11.4 | -7.63 | -19.46 | -9.74 | -27.58 |
Other Financing Activities | -91.27 | -6.32 | -5.51 | -15.14 | -13.27 | 40.82 |
Financing Cash Flow | 564.22 | 142.67 | 57.72 | 107.14 | 6.9 | 4.54 |
Foreign Exchange Rate Adjustments | 9.35 | 10.77 | 3.18 | 3.21 | -1.3 | -2.65 |
Net Cash Flow | -15.56 | 74.66 | -49.59 | 113.51 | 14.97 | -30.39 |
Free Cash Flow | -103.79 | -78.83 | -110.86 | 2.58 | 9.75 | -27.11 |
Free Cash Flow Growth | - | - | - | -73.57% | - | - |
Free Cash Flow Margin | -5.70% | -4.95% | -7.78% | 0.24% | 1.36% | -6.39% |
Free Cash Flow Per Share | -0.78 | -0.71 | -1.00 | 0.02 | 0.09 | - |
Cash Income Tax Paid | 32.96 | 20.01 | 32.79 | -13.67 | -6.64 | -4.62 |
Levered Free Cash Flow | - | -220.63 | -172.18 | -64.96 | -15.04 | -69.58 |
Unlevered Free Cash Flow | - | -214.36 | -168.86 | -62.2 | -13.4 | -68.27 |
Change in Working Capital | 66.63 | 66.63 | -71.06 | 71.4 | 17.6 | -26.92 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.